Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.81 |
| ▸ | SQLE | Q14534 | 8/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 1/20 | 0.52 |
| ▸ | FNTB | P49356 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1716636 | 1.00 | KMT2A (0.81) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL4663420 | 1.00 | KMT2A (0.81) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL1716635 | 1.00 | KMT2A (0.81) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL19327214 | 1.00 | KMT2A (0.81) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL23802597 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL4444267 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL2799805 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL21823197 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL21639794 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL39067 | 0.90 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021132214-A1 | α-HYDROXYISOBUTYRIC ACID ESTER COMPOUND AND FRAGRANCE COMPOSITION | 三菱瓦斯化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-11-13 | — | — | US | disclosed |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-10-23 | — | — | US | disclosed |
| US-7425320-B2 | Use of guaiol for treating the skin | CIBA SPECIALTY CHEMICALS CORP (US) | 2008-09-16 | — | — | US | disclosed |
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | BASCHONG WERNER | 2007-09-20 | — | — | US | disclosed |
| EP-1737419-A2 | USE OF BENZOPHENONE UV FILTERS FOR PREVENTING TANNING | Ciba SC Holding AG (CH) | 2007-01-03 | — | — | EP | disclosed |
| US-20060216252-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-09-28 | — | — | US | disclosed |
| WO-2005094772-A2 | USE OF BENZOPHENONE UV FILTERS FOR PREVENTING TANNING | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-10-13 | — | — | WO | disclosed |
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | CIBA SPECIALTY CHEMICALS CORP. | 2005-03-17 | — | — | US | disclosed |
| US-5738693-A | REACTING WITH DIAZONIUM SALT TO FORM AZO DYE | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| US-5627077-A | DETECTION OF MARKED MINERAL OILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-06 | — | — | US | disclosed |
| EP-0716743-A1 | METHOD OF DETECTING NAPHTHYLAMINES IN MINERAL OILS | BASF AKTIENGESELLSCHAFT (DE) | 1996-06-19 | — | — | EP | disclosed |
| EP-0673919-A1 | Process for the preparation of carbocylic m-amino-hydroxyaromatic compounds | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-27 | — | — | EP | disclosed |
| WO-1995007460-A1 | METHOD OF DETECTING NAPHTHYLAMINES IN MINERAL OILS | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-16 | — | — | WO | disclosed |
| EP-0626992-A1 | METAL SALTS AS MARKING AGENTS FOR COMBUSTIBLE BITUMEN. | BASF ITALIA (IT) | 1994-12-07 | — | — | EP | disclosed |
| EP-0358080-B1 | Silicon naphthalocyanine with unsaturated ligands, and optical recording medium | BASF AG (DE) | 1993-12-01 | — | — | EP | disclosed |
| WO-1993016149-A1 | METAL SALTS AS MARKING AGENTS FOR COMBUSTIBLE BITUMEN | BASF ITALIA S.P.A. (IT) | 1993-08-19 | — | — | WO | disclosed |
| US-5047312-A | Absorption in near infrared, laser light | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| EP-0358080-A2 | Silicon naphthalocyanine with unsaturated ligands, and optical recording medium | BASF Aktiengesellschaft (DE) | 1990-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | TYR, MC1R, UNG | KMT2A 3538/4885SQLE 468/4885MAPT 673/4885 |
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | C1R, CBR3, AOC3 | KMT2A 3810/4885SQLE 1741/4885MAPT 4671/4885 |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | KMT2A 2258/4885SQLE 729/4885MAPT 4613/4885 |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | KMT2A 2258/4885SQLE 729/4885MAPT 4613/4885 |
| US-20060216252-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | KMT2A 2175/4885SQLE 772/4885MAPT 4638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.